| __timestamp | Alpine Immune Sciences, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 8494000000 |
| Thursday, January 1, 2015 | 16054000 | 9046000000 |
| Friday, January 1, 2016 | 23316000 | 9095000000 |
| Sunday, January 1, 2017 | 10626000 | 10554000000 |
| Monday, January 1, 2018 | 28970000 | 10775000000 |
| Tuesday, January 1, 2019 | 35847000 | 11355000000 |
| Wednesday, January 1, 2020 | 27185000 | 12340000000 |
| Friday, January 1, 2021 | 58742000 | 14277000000 |
| Saturday, January 1, 2022 | 70243000 | 14135000000 |
| Sunday, January 1, 2023 | 80904000 | 15048000000 |
| Monday, January 1, 2024 | 17232000000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceutical research, the commitment to innovation is paramount. Johnson & Johnson, a titan in the industry, has consistently invested in research and development (R&D) over the past decade. From 2014 to 2023, their R&D expenses have surged by approximately 77%, peaking at $15 billion in 2023. This unwavering dedication underscores their role as a leader in healthcare innovation.
Conversely, Alpine Immune Sciences, Inc., a burgeoning player, has shown remarkable growth in its R&D investments. Starting with a modest $12 million in 2014, their expenses have skyrocketed by over 560% to $81 million in 2023. This exponential increase highlights their aggressive pursuit of cutting-edge therapies.
While Johnson & Johnson's R&D spending dwarfs that of Alpine, the latter's rapid growth trajectory is a testament to its potential to disrupt the industry.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Biogen Inc.
Analyzing R&D Budgets: Johnson & Johnson vs Insmed Incorporated
Comparing Innovation Spending: Johnson & Johnson and Pharming Group N.V.
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.